Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lenalidomide-dexamethasone versus observation in high-risk smoldering myeloma after 12 years of median follow-up time: A randomized, open-label study.
Mateos MV, Hernández MT, Salvador C, Rubia J, de Arriba F, López-Corral L, Rosiñol L, Paiva B, Palomera L, Bargay J, Oriol A, Prosper F, López J, Arguiñano JM, Bladé J, Lahuerta JJ, San-Miguel J. Mateos MV, et al. Among authors: salvador c. Eur J Cancer. 2022 Oct;174:243-250. doi: 10.1016/j.ejca.2022.07.030. Epub 2022 Sep 5. Eur J Cancer. 2022. PMID: 36067617 Clinical Trial.
Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia.
Alvarez-Larrán A, Cervantes F, Pereira A, Arellano-Rodrigo E, Pérez-Andreu V, Hernández-Boluda JC, Ayats R, Salvador C, Muntañola A, Bellosillo B, Vicente V, Hernández-Nieto L, Burgaleta C, Xicoy B, Besses C. Alvarez-Larrán A, et al. Among authors: salvador c. Blood. 2010 Aug 26;116(8):1205-10; quiz 1387. doi: 10.1182/blood-2010-01-263319. Epub 2010 May 27. Blood. 2010. PMID: 20508163 Free article.
Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients.
Alvarez-Larrán A, Cervantes F, Bellosillo B, Giralt M, Juliá A, Hernández-Boluda JC, Bosch A, Hernández-Nieto L, Clapés V, Burgaleta C, Salvador C, Arellano-Rodrigo E, Colomer D, Besses C. Alvarez-Larrán A, et al. Among authors: salvador c. Leukemia. 2007 Jun;21(6):1218-23. doi: 10.1038/sj.leu.2404693. Epub 2007 Apr 12. Leukemia. 2007. PMID: 17519959
Impact of patient-general practitioner short-messages-based interaction on the control of hypertension in a follow-up service for low-to-medium risk hypertensive patients: a randomized controlled trial.
Carrasco MP, Salvador CH, Sagredo PG, Márquez-Montes J, González de Mingo MA, Fragua JA, Rodríguez MC, García-Olmos LM, García-López F, Carrero AM, Monteagudo JL. Carrasco MP, et al. IEEE Trans Inf Technol Biomed. 2008 Nov;12(6):780-91. doi: 10.1109/TITB.2008.926429. IEEE Trans Inf Technol Biomed. 2008. PMID: 19000959 Clinical Trial.
The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors.
Matarraz S, López A, Barrena S, Fernandez C, Jensen E, Flores J, Bárcena P, Rasillo A, Sayagues JM, Sánchez ML, Hernandez-Campo P, Hernandez Rivas JM, Salvador C, Fernandez-Mosteirín N, Giralt M, Perdiguer L, Orfao A. Matarraz S, et al. Among authors: salvador c. Leukemia. 2008 Jun;22(6):1175-83. doi: 10.1038/leu.2008.49. Epub 2008 Mar 13. Leukemia. 2008. PMID: 18337765
Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients.
Matarraz S, López A, Barrena S, Fernandez C, Jensen E, Flores-Montero J, Rasillo A, Sayagues JM, Sánchez ML, Bárcena P, Hernandez-Rivas JM, Salvador C, Fernandez-Mosteirín N, Giralt M, Perdiguer L, Laranjeira P, Paiva A, Orfao A. Matarraz S, et al. Among authors: salvador c. Cytometry B Clin Cytom. 2010 May;78(3):154-68. doi: 10.1002/cyto.b.20513. Cytometry B Clin Cytom. 2010. PMID: 20198685 Free article.
Evaluation of a telemedicine-based service for the follow-up and monitoring of patients treated with oral anticoagulant therapy.
Salvador CH, Ruiz-Sanchez A, González de Mingo MA, Carmona Rodríguez M, Carrasco MP, Sagredo PG, Fragua JA, Caballero-Martinez F, García-López F, Márquez-Montes JN, Monteagudo JL. Salvador CH, et al. IEEE Trans Inf Technol Biomed. 2008 Nov;12(6):696-706. doi: 10.1109/TITB.2008.910750. IEEE Trans Inf Technol Biomed. 2008. PMID: 19000948
Evaluation of a telemedicine service for the secondary prevention of coronary artery disease.
Blasco A, Carmona M, Fernández-Lozano I, Salvador CH, Pascual M, Sagredo PG, Somolinos R, Muñoz A, García-López F, Escudier JM, Mingo S, Toquero J, Moñivas V, González MA, Fragua JA, López-Rodríguez F, Monteagudo JL, Alonso-Pulpón L. Blasco A, et al. J Cardiopulm Rehabil Prev. 2012 Jan-Feb;32(1):25-31. doi: 10.1097/HCR.0b013e3182343aa7. J Cardiopulm Rehabil Prev. 2012. PMID: 22113368 Clinical Trial.
297 results